202 related articles for article (PubMed ID: 38379051)
1. Multimodal and spatially resolved profiling identifies distinct patterns of T cell infiltration in nodal B cell lymphoma entities.
Roider T; Baertsch MA; Fitzgerald D; Vöhringer H; Brinkmann BJ; Czernilofsky F; Knoll M; Llaó-Cid L; Mathioudaki A; Faßbender B; Herbon M; Lautwein T; Bruch PM; Liebers N; Schürch CM; Passerini V; Seifert M; Brobeil A; Mechtersheimer G; Müller-Tidow C; Weigert O; Seiffert M; Nolan GP; Huber W; Dietrich S
Nat Cell Biol; 2024 Mar; 26(3):478-489. PubMed ID: 38379051
[TBL] [Abstract][Full Text] [Related]
2. PD1
Wickenden K; Nawaz N; Mamand S; Kotecha D; Wilson AL; Wagner SD; Ahearne MJ
Diagn Pathol; 2018 Sep; 13(1):74. PubMed ID: 30219078
[TBL] [Abstract][Full Text] [Related]
3. Non-Hodgkin lymphoma subtype distribution, geodemographic patterns, and survival in the US: A longitudinal analysis of the National Cancer Data Base from 1998 to 2011.
Al-Hamadani M; Habermann TM; Cerhan JR; Macon WR; Maurer MJ; Go RS
Am J Hematol; 2015 Sep; 90(9):790-5. PubMed ID: 26096944
[TBL] [Abstract][Full Text] [Related]
4. Investigation of lymphoid lesions of the head and neck using combined fine needle aspiration cytology and flow cytometry: Accuracy and pitfalls.
Crous H; Gillam A; Kalokerinos MA; Knezevic S; Hobson P; Papadimos DJ; Shield PW
Cytopathology; 2019 Jul; 30(4):370-377. PubMed ID: 30985042
[TBL] [Abstract][Full Text] [Related]
5. CD80 (B7.1) is expressed on both malignant B cells and nonmalignant stromal cells in non-Hodgkin lymphoma.
Dakappagari N; Ho SN; Gascoyne RD; Ranuio J; Weng AP; Tangri S
Cytometry B Clin Cytom; 2012 Mar; 82(2):112-9. PubMed ID: 22076940
[TBL] [Abstract][Full Text] [Related]
6. Eosinophil-rich variant of nodal marginal zone lymphoma: a clinicopathological study of 11 cases.
Miyake M; Sakata S; Tsuyama N; Togashi Y; Noguchi M; Tsukada N; Kumagai T; Mishima Y; Takeuchi K
Histopathology; 2023 Sep; 83(3):443-452. PubMed ID: 37222201
[TBL] [Abstract][Full Text] [Related]
7. Expansion of PD1-positive T Cells in Nodal Marginal Zone Lymphoma: A Potential Diagnostic Pitfall.
Egan C; Laurent C; Alejo JC; Pileri S; Campo E; Swerdlow SH; Piris M; Chan WC; Warnke R; Gascoyne RD; Xi L; Raffeld M; Pittaluga S; Jaffe ES
Am J Surg Pathol; 2020 May; 44(5):657-664. PubMed ID: 31764221
[TBL] [Abstract][Full Text] [Related]
8. Elevated monoclonal and polyclonal serum immunoglobulin free light chain as prognostic factors in B- and T-cell non-Hodgkin lymphoma.
Witzig TE; Maurer MJ; Habermann TM; Link BK; Micallef IN; Nowakowski GS; Ansell SM; Colgan JP; Inwards DJ; Porrata LF; Markovic SN; Johnston PB; Lin Y; Thompson C; Gupta M; Katzmann JA; Cerhan JR
Am J Hematol; 2014 Dec; 89(12):1116-20. PubMed ID: 25228125
[TBL] [Abstract][Full Text] [Related]
9. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
10. Immunopathology of non-Hodgkin lymphomas.
Huber H; Gattringer C; Knapp W; Stein H
Klin Wochenschr; 1984 Nov; 62(21):1001-10. PubMed ID: 6392723
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical expression of angiogenic cytokines and their receptors in reactive benign lymph nodes and non-Hodgkin lymphoma.
Ho CL; Sheu LF; Li CY
Ann Diagn Pathol; 2003 Feb; 7(1):1-8. PubMed ID: 12616467
[TBL] [Abstract][Full Text] [Related]
12. Myeloid cell nuclear differentiation antigen is expressed in a subset of marginal zone lymphomas and is useful in the differential diagnosis with follicular lymphoma.
Metcalf RA; Monabati A; Vyas M; Roncador G; Gualco G; Bacchi CE; Younes SF; Natkunam Y; Freud AG
Hum Pathol; 2014 Aug; 45(8):1730-6. PubMed ID: 24925224
[TBL] [Abstract][Full Text] [Related]
13. The feature of distribution and clonality of TCR γ/δ subfamilies T cells in patients with B-cell non-Hodgkin lymphoma.
Wang L; Xu M; Wang C; Zhu L; Hu J; Chen S; Wu X; Li B; Li Y
J Immunol Res; 2014; 2014():241246. PubMed ID: 24963496
[TBL] [Abstract][Full Text] [Related]
14. [Clinicopathological characteristics and prognosis of non-Hodgkin lymphoma in oral and maxillofacial regions: An analysis of 369 cases].
Su Q; Peng X; Zhou CX; Yu GY
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Feb; 55(1):13-21. PubMed ID: 36718684
[TBL] [Abstract][Full Text] [Related]
15. Composite marginal zone B-cell lymphoma and classical Hodgkin's lymphoma: a clinicopathological study of 12 cases.
Zettl A; Rüdiger T; Marx A; Müller-Hermelink HK; Ott G
Histopathology; 2005 Feb; 46(2):217-28. PubMed ID: 15693895
[TBL] [Abstract][Full Text] [Related]
16. Reactive T cells by flow cytometry distinguish Hodgkin lymphomas from T cell/histiocyte-rich large B cell lymphoma.
Wu D; Thomas A; Fromm JR
Cytometry B Clin Cytom; 2016 Sep; 90(5):424-32. PubMed ID: 26084540
[TBL] [Abstract][Full Text] [Related]
17. Composite Follicular Lymphoma and CD5-Positive Nodal Marginal Zone Lymphoma.
Miyaoka M; Kikuchi T; Carreras J; Yara Kikuti Y; Omachi K; Kojima M; Ando K; Nakamura N
J Clin Exp Hematop; 2016; 56(1):55-8. PubMed ID: 27334859
[TBL] [Abstract][Full Text] [Related]
18. Primary extra nodal non Hodgkin lymphoma: a 5 year retrospective analysis.
Padhi S; Paul TR; Challa S; Prayaga AK; Rajappa S; Raghunadharao D; Sarangi R
Asian Pac J Cancer Prev; 2012; 13(10):4889-95. PubMed ID: 23244076
[TBL] [Abstract][Full Text] [Related]
19. Soluble and membrane-bound TGF-β-mediated regulation of intratumoral T cell differentiation and function in B-cell non-Hodgkin lymphoma.
Yang ZZ; Grote DM; Ziesmer SC; Xiu B; Yates NR; Secreto FJ; Hodge LS; Witzig TE; Novak AJ; Ansell SM
PLoS One; 2013; 8(3):e59456. PubMed ID: 23555036
[TBL] [Abstract][Full Text] [Related]
20. New developments in non-Hodgkin lymphoid malignancies.
Ganapathi KA; Brown LE; Prakash S; Bhargava P
Pathology; 2021 Apr; 53(3):349-366. PubMed ID: 33685720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
